Depth of response and progression free survival in CLL patients on ibrutinib.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.7514
Abstract: 7514Background: While it has been established that attainment of a complete response (CR) after chemoimmunotherapy improves progression free survival (PFS), this has not been proven with the BTK in... read more here.
Keywords: depth response; free survival; progression free; response progression ... See more keywords